Stock Analysis

The Bull Case For Ally Financial (ALLY) Could Change Following Mounting Capital Ratio And Earnings Pressures

  • In recent years, Ally Financial has faced a 3.2% annual sales decline and falling earnings per share, while its tier one capital ratio stands at 9.7%, raising questions about balance sheet resilience as of today, 9 December 2025.
  • These pressures suggest investors are increasingly focused on whether Ally’s current capital and earnings profile can withstand a more challenging credit and funding backdrop.
  • We’ll now examine how concerns over Ally’s relatively low tier one capital ratio may reshape the company’s existing investment narrative.

Find companies with promising cash flow potential yet trading below their fair value.

Ally Financial Investment Narrative Recap

To own Ally Financial today, you need to believe its digital banking and auto finance franchise can still compound value despite recent sales pressure and a modest 9.7% tier one capital ratio. The latest figures sharpen near term focus on credit quality and funding costs, but do not obviously change the key catalyst of improving net interest margins or the biggest current risk of credit losses if the economy weakens.

The most relevant recent development is Ally’s Q3 2025 earnings, which showed net income of US$398,000,000 and EPS of US$1.18 despite earlier quarters being hit by a US$423,000,000 one off loss. That mix of recovering profitability and prior one offs frames how investors interpret today’s lower capital cushion against any future credit or funding stress.

Yet investors should pay close attention to how a weaker capital position could interact with rising credit uncertainty and...

Read the full narrative on Ally Financial (it's free!)

Ally Financial’s narrative projects $9.6 billion revenue and $1.8 billion earnings by 2028. This requires 12.0% yearly revenue growth and about a $1.5 billion earnings increase from $324.0 million today.

Uncover how Ally Financial's forecasts yield a $48.06 fair value, a 13% upside to its current price.

Exploring Other Perspectives

ALLY 1-Year Stock Price Chart
ALLY 1-Year Stock Price Chart

Nine members of the Simply Wall St Community currently see Ally’s fair value anywhere between US$36.04 and US$56.49 per share, reflecting a wide spread of expectations. You can weigh those views against concerns that a 9.7% tier one capital ratio may leave Ally more exposed if consumer credit conditions soften, and consider how that might shape the company’s resilience and earnings quality.

Explore 9 other fair value estimates on Ally Financial - why the stock might be worth 15% less than the current price!

Build Your Own Ally Financial Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

No Opportunity In Ally Financial?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

The New Payments ETF Is Live on NASDAQ:

Money is moving to real-time rails, and a newly listed ETF now gives investors direct exposure. Fast settlement. Institutional custody. Simple access.

Explore how this launch could reshape portfolios

Sponsored Content

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NYSE:ALLY

Ally Financial

A digital financial-services company, provides various digital financial products and services in the United States, Canada, and Bermuda.

Flawless balance sheet with moderate growth potential.

Weekly Picks

WO
MGPI logo
woodworthfund on MGP Ingredients ·

THE KINGDOM OF BROWN GOODS: WHY MGPI IS BEING CRUSHED BY INVENTORY & PRIMED FOR RESURRECTION

Fair Value:US$4034.1% undervalued
23 users have followed this narrative
4 users have commented on this narrative
5 users have liked this narrative
DO
Double_Bubbler
EVTL logo
Double_Bubbler on Vertical Aerospace ·

Why Vertical Aerospace (NYSE: EVTL) is Worth Possibly Over 13x its Current Price

Fair Value:US$6089.9% undervalued
23 users have followed this narrative
3 users have commented on this narrative
17 users have liked this narrative
TI
TickerTickle
ORCL logo
TickerTickle on Oracle ·

The Quiet Giant That Became AI’s Power Grid

Fair Value:US$389.8149.0% undervalued
43 users have followed this narrative
4 users have commented on this narrative
8 users have liked this narrative

Updated Narratives

IM
HOH logo
Imthetxarbi on High Arctic Overseas Holdings ·

Deep Value Multi Bagger Opportunity

Fair Value:CA$471.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AG
Agricola
EXN logo
Agricola on Excellon Resources ·

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ST
stuart_roberts
UNCY logo
stuart_roberts on Unicycive Therapeutics ·

Unicycive Therapeutics (Nasdaq: UNCY) – Preparing for a Second Shot at Bringing a New Kidney Treatment to Market (TEST)

Fair Value:US$21.5370.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.4% undervalued
120 users have followed this narrative
11 users have commented on this narrative
22 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3927.7% undervalued
963 users have followed this narrative
6 users have commented on this narrative
25 users have liked this narrative
RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8683.3% undervalued
78 users have followed this narrative
8 users have commented on this narrative
21 users have liked this narrative